Abstract

Microalgae represent one of the most promising sources of bioactive compounds for the pharmaceutical and food industries. Among these bioactives, carotenoids could be highlighted due to their health-promoting effects, including anti-inflammatory, neuroprotective or antioxidant properties. In this study, diverse microalgae extracts enriched in carotenoids, including extracts from Haematococcus pluvialis , Nannochloropsis oceanica , Tisochrysis lutea and Porphyridium cruentum , were evaluated through a battery of in vitro neuroprotective assays in an effort to estimate their potential against neurological disorders. Results indicated that microalgae extracts exerted a moderate and selective cholinesterase inhibitory potential, as well as high antioxidant and anti-inflammatory capacities, highlighting N. oceanica and T. lutea extracts. In parallel, cytotoxicity tests and evaluation of the anti-inflammatory capacity of the microalgae extracts were performed using different models. In this regard, N. oceanica extract showed the highest inhibition of pro-inflammatory cytokine release, indicating that this microalga extract could be the most promising neuroprotective agent. • PLE allows to recover potentially neuroprotective carotenoids from microalgae. • Carotenoids-enriched extracts present moderate in vitro anti-cholinergic activity. • The extracts lack of toxicity in HK2, THP-1 and SH-SY5Y cell lines below 50 μg mL −1 . • N. oceanica extract inhibits release of pro-inflammatory cytokines in THP-1 cells.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call